The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...
Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study ...
Spero Therapeutics, a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...
Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the firs...
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at...
Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the ...
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...
Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National M...
UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...
Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...
Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...
Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....
